中国医科大学学报

中国医科大学学报
  • 中文核心期刊
  • 中国科技核心期刊
  • 中国高校百佳科技期刊
  • BA、CA收录

中国医科大学学报 ›› 2018, Vol. 47 ›› Issue (10): 881-885,890.doi: 10.12007/j.issn.0258-4646.2018.10.004

• 论著 • 上一篇    下一篇

NFκB活化受体因子在胃癌中的表达及临床意义

李冬阳, 李智, 曲晶磊, 曲秀娟, 刘云鹏   

  1. 中国医科大学附属第一医院肿瘤内科, 沈阳 110001
  • 收稿日期:2018-02-23 出版日期:2018-10-30 发布日期:2018-09-30
  • 通讯作者: 刘云鹏 E-mail:cmuliuyunpeng@hotmail.com
  • 作者简介:李冬阳(1987-),女,医师,硕士.
  • 基金资助:
    国家自然科学基金(81572374);辽宁省教育厅重点实验室基础研究项目(LZ2015073);辽宁省“百千万人才工程”(2014921032);辽宁省教育厅科学研究一般项目(L2012293);沈阳市重点科技研发计划(17-230-9-01)

Expression and Clinical Significance of Receptor Activator of NF-κB in Gastric Carcinoma

LI Dongyang, LI Zhi, QU Jinglei, QU Xiujuan, LIU Yunpeng   

  1. Department of Oncology, The First Hospital, China Medical University, Shenyang 110001, China
  • Received:2018-02-23 Online:2018-10-30 Published:2018-09-30

摘要: 目的 检测NF-κB活化受体因子(RANK)蛋白在胃癌中的表达情况,分析RANK蛋白与胃癌临床病理特征的关系及其对生存的影响,旨在探讨RANK在胃癌中的表达及临床意义。方法 选取中国医科大学附属第一医院2006年4月至2011年12月手术切除的胃癌组织标本232例,术前均未行放疗、化疗及免疫治疗。采集患者基本信息及手术、病理等相关信息,所有患者均接受随访。结果 RANK表达与性别、年龄、浸润深度、临床分期以及淋巴结转移等病理因素无显著相关性,与Lauren分型相关(P=0.001);在生存方面,RANK阳性的患者表现出生存劣势,无统计学差异(P=0.306)。亚组分析显示,肠型胃癌中,RANK的表达与年龄(P=0.032)和淋巴结转移度相关(P=0.032);在生存方面,RANK阳性的患者表现出生存劣势,有统计学意义(P=0.016)。结论 RANK可能是一个与胃癌发生发展相关的有价值的分子标记物,可以成为肠型胃癌诊断和治疗的一个新的作用靶点。

关键词: NF-κB活化受体因子, 胃癌, Lauren分型, 淋巴结转移度, 生存率

Abstract: Objective This study analyzed the correlation of RANK expression with the clinical and pathological features of gastric carcinoma,to investigate the clinical implications by using the streptavidin-peroxidase immunohistochemical technique. Methods Specimens of gastric carcinoma were collected from 232 patients who underwent surgical resection at the First Affiliated Hospital of China Medical University between April 2006 and December 2011,and did not receive preoperative radiotherapy,chemotherapy,and immunotherapy. Results The RANK expression did not correlate with sex,age,depth of invasion,lymph node metastasis,and clinical staging (P > 0.05)but correlated with Lauren grade (P=0.001). In the intestinal gastric cancer analysis,the RANK expression did not correlate with sex,depth of invasion,lymph node metastasis,and clinical staging (P > 0.05)but correlated with age (P=0.032)and lymph node metastasis (P=0.032). RANK status did not significantly correlate with overall survival,but the intestinal gastric cancer subgroup analysis revealed that the RANK-positive patients had a shorter survival than the RANK-negative patients (P=0.016). Conclusion We may speculate that RANK expression may be a valuable molecular marker related to the development of gastric cancer and may be a new target for the diagnosis and treatment of intestinal type gastric cancer.

Key words: receptor activator of NF-κB, gastric carcinoma, Lauren grade, lymph node metastasis rate, survival rate

中图分类号: 

  • R735
[1] 孙秀娣,牧人,周有尚,等.中国胃癌死亡率20年变化情况分析及其发展趋势预测[J].中华肿瘤杂志,2004,26(1):4-9. DOI:10.3760/j.issn:0253-3766.2004.01.002.
[2] DOUGALL WC,GLACCUM M,CHARRIER K,et al. RANK is essential for osteoclast and lymph node development[J]. Genes Dev, 1999,13(18):2412-2424. DOI:10.1101/gad.13.18.2412.
[3] LI J,SAROSI I,YAN XQ,et al. RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism[J]. Proc Natl Acad Sci USA, 2000,97(4):1566-1571. DOI:10.1073/pnas.97.4.1566.
[4] TAT ST,PELLETIER JP,VELASCO CR,et al. New perspective in osteoarthritis:the OPG and RANKL system as a potential therapeutic target?[J]. Keio J Med,2009,58:29-40. DOI:10.2302/kjm.58.29.
[5] BOYCE BF,XING L. Functions of RANKL/RANK/OPG in bone modeling and remodeling. Archives of biochemistry and biophysics[J]. Arch Biochem Biophys,2008,473:139-146.DOI:10.1016/j.abb.2008.03.018.
[6] JONES D H,NAKASHIMA T,SANCHEZ OH,et al. Regulation of cancer cell migration and bone metastasis by RANKL[J]. Nature, 2006,440(7084):692-696. DOI:10.1038/nature04524.
[7] SANTINI D,PERRONE G,ROATO I,et al.Expression pattern of receptor activator of NFκB(RANK)in a series of primary solid tumor and related bone metastases[J]. J Cell Physiol,2011,226(3):780-784.DOI:10.1002/jcp.22402.
[8] CHEN LM,KUO CH,LAI TY,et al. RANKL increases migration of human lung cancer cells through intercellular adhesion molecule-1 up-regulation[J]. J Cell Biochem,2011,112(3):933-941. DOI:10.1002/jcb.23009.
[9] BHANSEN MF. Expression of receptor activator of nuclear factor -kappaB is inversely correlated with metastasis phenotype in breast carcinoma[J]. Clin Cancer Res,2005,11(1):162-165.
[10] BOYCE BF,XING L. Biology of RANK,RANKL,and osteoprotegerin[J]. Arthritis Res Ther,2007,9(Suppl 1):S1. DOI:10.1186/ar2165.
[11] WITTRANT Y,LAMOUREUX F,MORI K,et al. RANKL directly induces bone morphogenetic protein-2 expression in RANK-expressing POS-1 osteosarcoma cells[J]. Int J Oncol,2006,28(1):261-269. DOI:10.3892/ijo.28.1.261.
[12] MORI K,BERREUR M,BLANCHARD F,et al. Receptor activator of nuclear factor-kappaB ligand(RANKL)directly modulates the gene expression profile of RANK-positive Saos-2 human osteosarcoma cells[J]. Oncol Rep,2007,18(6):1365-1371.DOI:10.3892/or.18.6.1365.
[13] HSU CJ,LIN TY,KUO CC,et al. Involvement of integrin up-regulation in RANKL/RANK pathway of chondrosarcomas migration[J]. J Cell Biochem,2010,111(1):138-147. DOI:10.1002/jcb.22677.
[14] THOMAS RJ,GUISE TA,YIN JJ,et al. Breast cancer cells interact with osteoblasts to support osteoclast formation[J]. Endocrinology, 1999,140(10):4451-4458. DOI:10.1210/endo.140.10.7037.
[15] MORI K,LE GOFF B,CHARRIER C,et al. DU145 human prostate cancer cells express functional receptor activator of NF-kappaB:new insights in the prostate cancer bone metastasis process[J]. Bone, 2007,40(4):981-990. DOI:10.1016/j.bone.2006.11.006.
[16] ARMSTRONG AP,MILLER RE,JONES JC,et al. RANKL acts directly on RANK-expressing prostate tumor cells and mediates migration and expression of tumor metastasis genes[J]. Prostate,2008, 68(1):92-104. DOI:10.1002/pros.20678.
[17] MIKAMI S,KATSUBE K,OYA M,et al. Increased RANKL expression is related to tumour migration and metastasis of renal cell carcinomas[J]. J Pathol,2009,218(4):530-539. DOI:10.1002/path.2567.
[18] CHUANG FH,HSUE SS,WU CW,et al. Immunohistochemical expression of RANKL,RANK,and OPG in human oral squamous cell carcinoma[J]. J Oral Pathol Med,2009,38(10):753-758. DOI:10.1111/j.1600-0714.2009.00793.x.
[19] HEYMANN MF,RIET A,LE GOFF B,et al. OPG,RANK and RANK ligand expression in thyroid lesions[J]. Regul Pept,2008, 148(1/3):46-53. DOI:10.1016/j.regpep.2008.02.004.
[20] KUPAS V,WEISHAUPT C,SIEPMANN D,et al. RANK is expressed in metastatic melanoma and highly upregulated on melanoma-initiating cells[J]. J Invest Dermatol,2011,131(4):944-955. DOI:10.1016/j.regpep.2008.02.004.
[21] MORI K,ANDO K,HEYMANN D,et al. Receptor activator of nuclear factor-kappa B ligand(RANKL)stimulates bone-associated tumors through functional RANK expressed on bone-associated cancer cells?[J]. Histol Histopathol,2009,24(2):235-242. DOI:10.14670/HH-24.235.
[22] KONG YY,YOSHIDA H,SAROSI I,et al. OPGL is a key regulator of osteoclastogenesis,lymphocyte development and lymphnode organogenesis[J]. Nature,1999,397(6717):315-323. DOI:10.1038/16852.
[23] KIM N,ODGREN PR,KIM DK,et al. Diverse roles of the tumor necrosis factor family member TRANCE in skeletal physiology revealed by TRANCE deficiency and partial rescue by a lymphocyte-expressed TRANCE transgene[J]. Proc Natl Acad Sci USA, 2000,97(20):10905-10910. DOI:10.1073/pnas.200294797.
[24] KUSUMOTO H,HARAGUCHI M,NOZUKA Y,et al. Characteristic features of disseminated carcinomatosis of the bone marrow due to gastric cancer:the pathogenesis of bone destruction[J]. Oncol Rep, 2006,16(4):735-740. DOI:10.3892/or.16.4.735.
[25] D'AMICO L,SATOLLI MA,MECCA C,et al. Bone metastases in gastric cancer follow a RANKL-independent mechanism[J]. Oncol Rep,2013,29(4):1453-1458. DOI:10.3892/or.2013.2280.
[26] SANTINI D,SCHIAVON G,VINCENZI B,et al. Receptor activator of NF-kB(RANK)expression in primary tumors associates with bone metastasis occurrence in breast cancer patients[J]. PLoS One, 2011,29,6(4):e19234. DOI:10.1371/journal.pone.0019234.
[27] ITO R,NAKAYAMA H,YOSHIDA K,et al. Expression of osteoprotegerin correlates with aggressiveness and poor prognosis of gastric carcinoma[J]. Virchows Arch,2003,443(2):146-151. DOI:10.1007/s00428-003-0845-8.
[1] 马艺文, 谭继超, 张宇, 代伟宏, 张瑜, 林荣锦, 罗阳, 徐岩. 新抑癌基因INPP4B在EB病毒相关胃癌中的表达及其临床意义[J]. 中国医科大学学报, 2019, 48(7): 587-590,600.
[2] 郅重阳, 彭良群, 张占东, 李宁, 刘洪兴, 花亚伟. 倾向评分匹配法探讨预后营养指数与胃癌新辅助化疗后病理完全缓解的相关性[J]. 中国医科大学学报, 2019, 48(3): 245-249,254.
[3] 李汉文, 刘玲玲, 李亘松, 朱铄同, 李春雨, 邓欣. 油封M2与M16培养液及二甲基亚砜对小鼠双线期阻滞释放期间卵母细胞的影响[J]. 中国医科大学学报, 2019, 48(2): 132-135.
[4] 徐国帅, 蔡相军, 陈江波, 吕庆, 刘洪涛. AEG-1和CHD5在胃癌中的表达及其临床意义[J]. 中国医科大学学报, 2018, 47(9): 797-802.
[5] 宋宠, 劳力军. 神经节苷脂GD3和CD3+T淋巴细胞在胃癌中的表达及相关性研究[J]. 中国医科大学学报, 2018, 47(5): 435-438,442.
[6] 范一博, 车晓芳, 赵欢, 胡雪君, 曲秀娟, 刘云鹏. microRNA-1183通过抑制CBL-B的表达促进胃癌细胞的增殖及转移[J]. 中国医科大学学报, 2018, 47(3): 202-205,211.
[7] 王雷, 杜媛鲲, 米源, 廖海江, 陈阁, 张耀中, 刘庆熠. Hedgehog/Gli和PI3K/AKT信号通路的串话促进胃癌AZ521细胞上皮-间质转化[J]. 中国医科大学学报, 2018, 47(2): 151-156.
[8] 王冰, 黄宝俊, 解大龙, 赵丹懿. 沉默长链非编码RNA浆细胞瘤可变易位1基因提高胃癌细胞对阿霉素的化疗敏感性[J]. 中国医科大学学报, 2018, 47(12): 1081-1084,1106.
[9] 赵雪峰, 赵美兰, 许广大. TMPRSS4在胃癌中的表达及其临床意义[J]. 中国医科大学学报, 2018, 47(11): 969-974.
[10] 李丹 ,黄宝俊 ,赵丹懿. 远端上游元件结合蛋白 1 在胃癌中的表达及其对胃癌细胞 增殖和侵袭能力的影响[J]. 中国医科大学学报, 2017, 46(7): 587-590.
[11] 周立霞,吴月明,李娜,杨祎,秦雪云. 毛蕊异黄酮增强顺铂对胃癌细胞增殖的抑制作用[J]. 中国医科大学学报, 2017, 46(1): 50-54.
[12] 张超 ,王爱平 ,景丽伟 ,,刘诗盈 ,徐蕾 ,闫蕾 ,易红杰. 胃癌患者焦虑状况与心理韧性及希望水平的相关性[J]. 中国医科大学学报, 2016, 45(8): 739-741.
[13] 杨雪峰,勾文峰,赵爽,申道福,吴亚州,李君君,郑华川. ING5 基因表达对胃癌细胞生长抑制作用的研究[J]. 中国医科大学学报, 2016, 45(7): 577-582.
[14] 杨庆林 ,郭晓东 ,张睿 ,陆航 ,张红. 胃癌组织中 HER-2 和 Survivin 蛋白的表达及临床意义[J]. 中国医科大学学报, 2016, 45(7): 616-619.
[15] 王硕,李智,郑春雷,曲秀娟,刘静,曲晶磊,车晓芳,刘云鹏. 利用TCGA数据集分析AKT3在胃癌中的表达及临床意义[J]. 中国医科大学学报, 2016, 45(5): 398-401.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] 贺雪梅, 熊欣, 邹建中, 李发琪, 龚晓波. 超声消融剂量与生物学焦域特征[J]. 中国医科大学学报, 2009, 38(9): 654 .
[2] 刘小霄, 宋薇薇. 印记基因H19和IGF-ⅡmRNA在新生儿胎盘中的表达与出生体质量的关系[J]. 中国医科大学学报, 2009, 38(10): 758 .
[3] 高红, 吕良英, 白伟良, 王大佳, 黄英, 张志波, 王维林. 先天性巨结肠组织蛋白质组成分的双向凝胶电泳分析[J]. 中国医科大学学报, 2009, 38(10): 761 .
[4] 蔡鑫泽, 顾卉, 刘彤, 李丰. hLMO1编码基因重组质粒的构建及蛋白的表达和定位[J]. 中国医科大学学报, 2009, 38(11): 816 .
[5] 贾兰玲, 陈相, 庹航行, 贾心善, 陈颖, 李继光. 大鼠海马神经细胞原代培养及塑料孔板原位鉴定[J]. 中国医科大学学报, 2009, 38(11): 843 .
[6] 张华, 王秋月, 侯刚, 许惟元, 李猛, 康健. 辽宁部分农村地区居民吸烟情况与COPD患病关系的调查[J]. 中国医科大学学报, 2009, 38(11): 855 .
[7] 张依宁, 魏敏杰, 孙明军. 伊立替康抑制人结直肠癌细胞增殖和ATP敏感性钾通道的相关性研究[J]. 中国医科大学学报, 2010, 39(1): 10 .
[8] 孔琳, 潘伯臣, 杜强, 杨大磊. 精子发生障碍患者Y染色体微缺失的检测[J]. 中国医科大学学报, 2010, 39(1): 37 .
[9] 孙桂莲, 江雅静, 姜琳, 王东颖, 杨志亮. 46例小儿周期性呕吐综合征的临床研究[J]. 中国医科大学学报, 2010, 39(1): 67 .
[10] 赵晓东, 舒红, 姜卫国, 杨向红. 微小活检组织的石蜡包埋及切片的制作方法[J]. 中国医科大学学报, 2010, 39(1): 76 .

中国医科大学学报版权所有©2018

未经允许,严禁擅自转载本站图文资料

地址:中国 沈阳市沈北新区蒲河路77号 110122

辽ICP备05014850

JOURNAL OF CHINA MEDICAL UNIVERSITY

ADDRESS: NO.77 PUHE ROAD

SHENYANG NORTH NEW AREA, SHENYANG

LIAONING PROVINCE, P.R. CHINA